关键词:

急性脑梗死, 临床效果, 疏血通

Abstract:

Objective　To study the clinical effect of Shuxuetong injection in the treatment of patients with acute cerebral infarction. Methods　Eighty-six patients with acute cerebral infarction treated at Zengguang Health Center from September 2022 to April 2023 were selected for the randomized controlled trial, and were divided into a control group and a Shuxuetong group by the random number table method, with 43 cases in each group. There were 20 males who were (60.63±2.39) years old and 23 females who were (63.16±1.38) years old in the control group. There were 21 males who were (58.08±2.35) years old and 22 females who were (63.72±2.87) years old in the Shuxuetong group. Both groups took routine treatment; in addition, the Shuxuetong group intravenously dripped 6 ml Shuxuetong added into 250 ml normal saline. Seven days were one treatment course, and both groups were treated 2 courses. The total effective rates, satisfaction rates, incidences of adverse reactions, physical signs, and scores of the Mos 36-Item Short Form Health Survey (SF-36) and traditional Chinese medicine symptoms were compared between the two groups by the rank sum test, χ² test, and t test. Results　After the treatment, the total effective rate and comprehensive treatment satisfaction rate in the Shuxuetong group were higher than those in the control group [95.35% (41/43) vs. 81.40% (35/43) and 97.67% (42/43) vs. 79.07% (34/43)], with statistical differences (χ²=4.07 and 7.24; both P<0.05). The incidence of adverse reactions in the control group was higher than that in the control group [27.91% (12/43) vs. 9.30% (4/43)], with a statistical difference (χ²=4.91; P<0.05). Before the treatment, there were no statistical differences in the physical signs and the scores of SF-36 and traditional Chinese medicine symptoms between the two groups (all P>0.05); after the treatment, the physical signs and the scores of SF-36 and traditional Chinese medicine symptoms in the Shuxuetong group were better than those in the control group (P<0.05). Conclusion　Routine treatment combined with Shuxuetong for patients with acute cerebral infarction is effective, with a high satisfaction rate and an effective rate, so it is worth being generalized.

Key words:

Acute cerebral infarction, Clinical effect, Shuxuetong